218 related articles for article (PubMed ID: 31729120)
21. Overexpression of MDM2 in acute childhood lymphoblastic leukemia.
Gustafsson B; Stål O; Gustafsson B
Pediatr Hematol Oncol; 1998; 15(6):519-26. PubMed ID: 9842645
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia.
Kiss R; Gángó A; Benard-Slagter A; Egyed B; Haltrich I; Hegyi L; de Groot K; Király PA; Krizsán S; Kajtár B; Pikó H; Pajor L; Vojcek Á; Matolcsy A; Kovács G; Szuhai K; Savola S; Bödör C; Alpár D
Mod Pathol; 2020 May; 33(5):812-824. PubMed ID: 31857684
[TBL] [Abstract][Full Text] [Related]
23. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
Vilas-Zornoza A; Agirre X; Martín-Palanco V; Martín-Subero JI; San José-Eneriz E; Garate L; Álvarez S; Miranda E; Rodríguez-Otero P; Rifón J; Torres A; Calasanz MJ; Cruz Cigudosa J; Román-Gómez J; Prósper F
PLoS One; 2011 Feb; 6(2):e17012. PubMed ID: 21386967
[TBL] [Abstract][Full Text] [Related]
24.
Comeaux EQ; Mullighan CG
Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28003275
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
26. Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.
Blau O; Avigad S; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
Leuk Res; 1997 Aug; 21(8):721-9. PubMed ID: 9379679
[TBL] [Abstract][Full Text] [Related]
27. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Irving JA; Enshaei A; Parker CA; Sutton R; Kuiper RP; Erhorn A; Minto L; Venn NC; Law T; Yu J; Schwab C; Davies R; Matheson E; Davies A; Sonneveld E; den Boer ML; Love SB; Harrison CJ; Hoogerbrugge PM; Revesz T; Saha V; Moorman AV
Blood; 2016 Aug; 128(7):911-22. PubMed ID: 27229005
[TBL] [Abstract][Full Text] [Related]
28. Prognosis and outcome of relapsed acute lymphoblastic leukemia: a Hong Kong Pediatric Hematology and Oncology Study Group report.
Leung AW; Vincent L; Chiang AK; Lee AC; Cheng FW; Cheuk DK; Luk CW; Ling SC; Li CK
Pediatr Blood Cancer; 2012 Sep; 59(3):454-60. PubMed ID: 22610685
[TBL] [Abstract][Full Text] [Related]
29. Strong expression of p53 protein in bone marrow samples after hematopoietic stem cell transplantation indicates risk of relapse in pediatric acute lymphoblastic leukemia patients.
Mattsson K; Honkaniemi E; Ramme K; Barbany G; Sander BM; Gustafsson BM
Pediatr Transplant; 2019 Jun; 23(4):e13408. PubMed ID: 30955249
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550
[TBL] [Abstract][Full Text] [Related]
31. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
Kanagal-Shamanna R; Jain P; Takahashi K; Short NJ; Tang G; Issa GC; Ravandi F; Garcia-Manero G; Yin CC; Luthra R; Patel KP; Khoury JD; Montalban-Bravo G; Sasaki K; Kadia TM; Borthakur G; Konopleva M; Jain N; Garris R; Pierce S; Wierda W; Estrov Z; Cortes J; O'Brien S; Kantarjian HM; Jabbour E
Cancer; 2017 Oct; 123(19):3717-3724. PubMed ID: 28608976
[TBL] [Abstract][Full Text] [Related]
32. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
Lawson SE; Harrison G; Richards S; Oakhill A; Stevens R; Eden OB; Darbyshire PJ
Br J Haematol; 2000 Mar; 108(3):531-43. PubMed ID: 10759711
[TBL] [Abstract][Full Text] [Related]
33. [Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].
Zheng YZ; Zheng H; Chen ZS; Hua XL; Le SH; Li J; Hu JD
Zhonghua Xue Ye Xue Za Zhi; 2022 Jan; 43(1):19-25. PubMed ID: 35231988
[No Abstract] [Full Text] [Related]
34. TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.
Stengel A; Schnittger S; Weissmann S; Kuznia S; Kern W; Kohlmann A; Haferlach T; Haferlach C
Blood; 2014 Jul; 124(2):251-8. PubMed ID: 24829203
[TBL] [Abstract][Full Text] [Related]
35. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
36. Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis.
Seeger K; von Stackelberg A; Taube T; Buchwald D; Körner G; Suttorp M; Dörffel W; Tausch W; Henze G
J Clin Oncol; 2001 Jul; 19(13):3188-93. PubMed ID: 11432885
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen.
Ou J; Xu X; Deng S; Liang H; Cai Z; Li J; Huang Z; Tang B; Wang Z; Zhou Y; Liu X; Liu Q; Zhou H
Leuk Lymphoma; 2024 Feb; 65(2):219-227. PubMed ID: 37938093
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
39. Analysis of p16 gene mutations and deletions in childhood acute lymphoblastic leukemias.
Lemos JA; Defavery R; Scrideli CA; Tone LG
Sao Paulo Med J; 2003 Mar; 121(2):58-62. PubMed ID: 12870051
[TBL] [Abstract][Full Text] [Related]
40. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
